Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene Ferrer

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
European Journal of Medical Genetics|December 17, 2009
Prenatal study of common submicroscopic "genomic disorders" using MLPA with subtelomeric/microdeletion syndrome probe mixes, among gestations with ultrasound abnormalities in the first trimesterMónica Roselló, Irene Ferrer-Bolufer, Sandra Monfort, et al.
Oncotarget|May 8, 2018
Histology-dependent prognostic role of pERK and p53 protein levels in early-stage non-small cell lung cancerÁlvaro Quintanal-Villalonga, Mariló Mediano, Irene Ferrer, et al.
Oncotarget|August 27, 2016
Efficacy of bortezomib in sarcomas with high levels of MAP17 (PDZK1IP1)Marco Perez, Javier Peinado-Serrano, Jose Manuel Garcia-Heredia, et al.
International Journal of Molecular Sciences|September 28, 2023
Inhibition of HSP90 in Driver Oncogene-Defined Lung Adenocarcinoma Cell Lines: Key Proteins Underpinning Therapeutic EfficacyÁngela Marrugal, Irene Ferrer, Álvaro Quintanal-Villalonga, et al.
American Journal of Medical Genetics. Part A|February 13, 2009
Novel UBE3A mutations causing Angelman syndrome: different parental origin for single nucleotide changes and multiple nucleotide deletions or insertionsCristina Camprubí, Miriam Guitart, Elisabeth Gabau, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 19, 2018
MAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinomaIrene Ferrer, Álvaro Quintanal-Villalonga, Sonia Molina-Pinelo, et al.
Clinical Lung Cancer|September 29, 2019
Blood Predictive Biomarkers for Patients With Non-small-cell Lung Cancer Associated With Clinical Response to NivolumabM Teresa Agulló-Ortuño, Óscar Gómez-Martín, Santiago Ponce, et al.
Carcinogenesis|January 22, 2008
PPP1CA contributes to the senescence program induced by oncogenic RasMaria E Castro, Irene Ferrer, Alberto Cascón, et al.
Cell Cycle (Georgetown, Tex.)|July 21, 2011
Spinophilin acts as a tumor suppressor by regulating Rb phosphorylationIrene Ferrer, Carmen Blanco-Aparicio, Sandra Peregrina, et al.
Scientific Reports|February 7, 2018
The FGFR4-388arg Variant Promotes Lung Cancer Progression by N-Cadherin InductionÁlvaro Quintanal-Villalonga, Laura Ojeda-Márquez, Ángela Marrugal, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
European Journal of Medical Genetics|December 17, 2009
Prenatal study of common submicroscopic "genomic disorders" using MLPA with subtelomeric/microdeletion syndrome probe mixes, among gestations with ultrasound abnormalities in the first trimesterMónica Roselló, Irene Ferrer-Bolufer, Sandra Monfort, et al.
Oncotarget|May 8, 2018
Histology-dependent prognostic role of pERK and p53 protein levels in early-stage non-small cell lung cancerÁlvaro Quintanal-Villalonga, Mariló Mediano, Irene Ferrer, et al.
Oncotarget|August 27, 2016
Efficacy of bortezomib in sarcomas with high levels of MAP17 (PDZK1IP1)Marco Perez, Javier Peinado-Serrano, Jose Manuel Garcia-Heredia, et al.
International Journal of Molecular Sciences|September 28, 2023
Inhibition of HSP90 in Driver Oncogene-Defined Lung Adenocarcinoma Cell Lines: Key Proteins Underpinning Therapeutic EfficacyÁngela Marrugal, Irene Ferrer, Álvaro Quintanal-Villalonga, et al.
American Journal of Medical Genetics. Part A|February 13, 2009
Novel UBE3A mutations causing Angelman syndrome: different parental origin for single nucleotide changes and multiple nucleotide deletions or insertionsCristina Camprubí, Miriam Guitart, Elisabeth Gabau, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 19, 2018
MAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinomaIrene Ferrer, Álvaro Quintanal-Villalonga, Sonia Molina-Pinelo, et al.
Clinical Lung Cancer|September 29, 2019
Blood Predictive Biomarkers for Patients With Non-small-cell Lung Cancer Associated With Clinical Response to NivolumabM Teresa Agulló-Ortuño, Óscar Gómez-Martín, Santiago Ponce, et al.
Carcinogenesis|January 22, 2008
PPP1CA contributes to the senescence program induced by oncogenic RasMaria E Castro, Irene Ferrer, Alberto Cascón, et al.
Cell Cycle (Georgetown, Tex.)|July 21, 2011
Spinophilin acts as a tumor suppressor by regulating Rb phosphorylationIrene Ferrer, Carmen Blanco-Aparicio, Sandra Peregrina, et al.
Scientific Reports|February 7, 2018
The FGFR4-388arg Variant Promotes Lung Cancer Progression by N-Cadherin InductionÁlvaro Quintanal-Villalonga, Laura Ojeda-Márquez, Ángela Marrugal, et al.
Pageof 7